Montforte et al performed a similar study comparing 120 days of VGCV to GCV prophylaxis in LTRs and they found a lower rate of CMV disease in the VGCV group, 16 versus 8%, but the difference did not reach statistical significance [ 16 ].
← all excerpts
Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients.
1
—
—